BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31473565)

  • 1. Generation of a CFTR knock-in reporter cell line (MHHi006-A-1) from a human induced pluripotent stem cell line.
    Engels L; Olmer R; de la Roche J; Göhring G; Ulrich S; Haller R; Martin U; Merkert S
    Stem Cell Res; 2019 Oct; 40():101542. PubMed ID: 31473565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
    Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
    Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.
    Crane AM; Kramer P; Bui JH; Chung WJ; Li XS; Gonzalez-Garay ML; Hawkins F; Liao W; Mora D; Choi S; Wang J; Sun HC; Paschon DE; Guschin DY; Gregory PD; Kotton DN; Holmes MC; Sorscher EJ; Davis BR
    Stem Cell Reports; 2015 Apr; 4(4):569-77. PubMed ID: 25772471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.
    Dębczyński M; Mojsak D; Tamburro S; Baldassari S; Musante I; Casciaro R; Ciciriello F; Zara F; Scudieri P; Gorrieri G
    Stem Cell Res; 2023 Oct; 72():103232. PubMed ID: 37865062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
    Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a NKX2.1 - p63 double transgenic knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-4).
    Drick N; Sahabian A; Pongpamorn P; Merkert S; Göhring G; Welte T; Martin U; Olmer R
    Stem Cell Res; 2020 Jan; 42():101659. PubMed ID: 31791010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation.
    Merkert S; Schubert M; Haase A; Janssens HM; Scholte B; Lachmann N; Göhring G; Martin U
    Stem Cell Res; 2020 Apr; 44():101744. PubMed ID: 32220772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a NKX2.1 knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-2).
    Olmer R; Dahlmann J; Merkert S; Baus S; Göhring G; Martin U
    Stem Cell Res; 2019 Aug; 39():101492. PubMed ID: 31299562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of two induced pluripotent stem cell lines (RCMGi004-A and -B) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/W1282X mutations in CFTR gene.
    Kondrateva E; Demchenko A; Slesarenko Y; Pozhitnova V; Yasinovsky M; Amelina E; Tabakov V; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2021 Apr; 52():102232. PubMed ID: 33607467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR.
    MacVinish LJ; Cope G; Ropenga A; Cuthbert AW
    Br J Pharmacol; 2007 Apr; 150(8):1055-65. PubMed ID: 17339840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a TALEN-mediated, p63 knock-in in human induced pluripotent stem cells.
    Kobayashi Y; Hayashi R; Quantock AJ; Nishida K
    Stem Cell Res; 2017 Dec; 25():256-265. PubMed ID: 29179035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
    Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway and Lung Organoids from Human-Induced Pluripotent Stem Cells Can Be Used to Assess CFTR Conductance.
    Demchenko A; Kondrateva E; Tabakov V; Efremova A; Salikhova D; Bukharova T; Goldshtein D; Balyasin M; Bulatenko N; Amelina E; Lavrov A; Smirnikhina S
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN.
    Merkert S; Bednarski C; Göhring G; Cathomen T; Martin U
    Stem Cell Res; 2017 Aug; 23():95-97. PubMed ID: 28925369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human induced pluripotent stem cells from cystic fibrosis patient carrying nonsense mutation (p.S308X) in CFTR gene.
    Khor W; Hwang TC; Wang CC; Yarmishyn AA; Yeh JT; Chiou SH; Chou SJ
    Stem Cell Res; 2022 Apr; 60():102683. PubMed ID: 35091309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.
    Verkman AS; Lukacs GL; Galietta LJ
    Curr Pharm Des; 2006; 12(18):2235-47. PubMed ID: 16787252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs.
    Firth AL; Menon T; Parker GS; Qualls SJ; Lewis BM; Ke E; Dargitz CT; Wright R; Khanna A; Gage FH; Verma IM
    Cell Rep; 2015 Sep; 12(9):1385-90. PubMed ID: 26299960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Induced Progenitor-like Cells from Mature Epithelial Cells Using Interrupted Reprogramming.
    Guo L; Karoubi G; Duchesneau P; Shutova MV; Sung HK; Tonge P; Bear C; Rogers I; Nagy A; Waddell TK
    Stem Cell Reports; 2017 Dec; 9(6):1780-1795. PubMed ID: 29198829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines.
    Cerbini T; Funahashi R; Luo Y; Liu C; Park K; Rao M; Malik N; Zou J
    PLoS One; 2015; 10(1):e0116032. PubMed ID: 25587899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TALEN-Mediated Gene Targeting for Cystic Fibrosis-Gene Therapy.
    Xia E; Zhang Y; Cao H; Li J; Duan R; Hu J
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30641980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.